You are here

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Paris, , 75015 France
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Alzheimer Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Young healthy subjects:

- Men and women of nonchildbearing potential (WONCBP) aged 18 to 45 years inclusive on
study day 1.

- Body mass index (BMI) in the range of 18 to 30 kg/m2 and body weight greater than or
equal to 50 kg and body weight greater than or equal to 50 kg.

Elderly Healthy subjects:

- Men or women aged 65 years and above as of study day 1.

- BMI in the range of 18 to 30 kg/m2 and body weight greater than or equal to 45 kg and
body weight greater than or equal to 45 kg.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal,
endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.

- History of any clinically important drug allergy.

NCT00474552
Pfizer
Terminated
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now